Search filters

List of works by Carmen Balaña

2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary

scientific article published on 28 May 2018

A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples

scientific article

A case of c-kit positive high-grade stromal endometrial sarcoma responding to Imatinib Mesylate.

scientific article

A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma

scientific article published on 23 February 2019

A phase I study of irinotecan in combination with metronomic temozolomide in patients with recurrent glioblastoma.

scientific article

A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary site.

scientific article published on September 2003

A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma.

scientific article published on 2 June 2015

ACTR-48. AN APPRAISAL OF THE IMPACT ON SURVIVAL OF NEOADJUVANT TREATMENTS DELAYING RADIOTHERAPY IN ‘ONLY-BIOPSIED GLIOBLASTOMA’ TRIALS CONDUCTED BY THE GEINO GROUP COMPARED TO PATIENTS TREATED WITH THE STUPP’S REGIME. EXPERIENCE OF THE GEINO AND THE

ATCT-05OBJECTIVE RESPONSE (OR) TO NEOADJUVANT TREATMENT IN GLIOBLASTOMA AND ITS IMPACT ON OVERALL SURVIVAL (OS). A META-ANALYSIS OF NEOADJUVANT TRIALS OF THE SPANISH GROUP FOR RESEARCH IN NEUROONCOLOGY (GEINO).

scientific article

Approval denied by the European Medicines Agency (EMA) for bevacizumab in the treatment of high-grade glioma recurrence: a good idea or a grave error?

scientific article

Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab

scientific article published on 29 May 2019

Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.

scientific article published on 3 February 2016

Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO).

scientific article published in July 2012

Bevacizumab rechallenge in glioblastoma patients with initial response to bevacizumab who later progress off therapy

scientific article published on 18 May 2018

Clinical course of high-grade glioma patients with a "biopsy-only" surgical approach: a need for individualised treatment.

scientific article

Correction to: SEOM clinical guidelines for anaplastic gliomas (2017)

scientific article published on 01 July 2018

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas

scientific article

Dacomitinib: an investigational drug for the treatment of glioblastoma

scientific article published on 05 October 2018

Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients.

scientific article

EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma.

scientific article published in August 2014

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

scientific article published on 08 December 2020

ET-12PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA.

scientific article published in November 2014

Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma

scientific article published on 25 November 2017

Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry

scientific article published on 19 December 2013

Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

scientific article published on 19 August 2019

Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis

scientific article published on 26 August 2016

Epirubicin plus a calmodulin inhibitor (trifluoperazine) activity in advanced pancreatic adenocarcinoma. T.T.D. Cooperative Spanish Group.

scientific article

Erratum to: Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry.

scientific article published on 28 October 2014

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.

scientific article published on 5 May 2017

Evidence-based management of adult patients with diffuse glioma - Authors' reply

scientific article

Evolution of care for patients with relapsed glioblastoma.

scientific article

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial.

scientific article

Extended-schedule dose-dense temozolomide in refractory gliomas

scientific article

Federated learning enables big data for rare cancer boundary detection

Genotyping low-grade gliomas among Hispanics

scientific article published on 28 January 2016

Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients

scientific article

IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.

scientific article published on 7 September 2017

Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study

scientific article published on 28 December 2017

Macrovascular Networks on Contrast-Enhanced Magnetic Resonance Imaging Improves Survival Prediction in Newly Diagnosed Glioblastoma

scientific article published on 14 January 2019

Medulloblastoma in young adults. Must we give adjuvant chemotherapy?

scientific article published in February 2007

Neoadjuvant cisplatin plus temozolomide versus standard treatment in patients with unresectable glioblastoma or anaplastic astrocytoma: a differential effect of MGMT methylation.

scientific article

P04.03 Extent of surgery improves the overall survival independently of imaging characteristics in newly diagnosed glioblastoma.

scientific article

P17.04RANO CRITERIA APPLIED TO A PHASE II RANDOMIZED, MULTICENTER TRIAL COMPARING TEMOZOLOMIDE (TMZ) VS TMZ-PLUS-BEVACIZUMAB (BEV) BEFORE STANDARD TREATMENT IN UNRESECTABLE GLIOBLASTOMA (GBM) PATIENTS (P).GENOM 009 STUDY BY THE GEINO GROUP.

scientific article

Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study.

scientific article published on 23 May 2006

Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.

scientific article

Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma.

scientific article published on 16 November 2015

Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors.

scientific article

Prolonged survival after bevacizumab rechallenge in glioblastoma patients with previous response to bevacizumab†

scientific article published on 09 December 2016

Pseudoprogression as an adverse event of glioblastoma therapy

scientific article published on 3 November 2017

Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients

scientific article published on 31 July 2019

Radiation and concomitant chemotherapy for patients with glioblastoma multiforme

scientific article

Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.

scientific article

Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Espanol de Investigacion en Cancer de Ovario) study.

scientific article published on 7 April 2005

Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine-DNA

scientific article

Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines

scientific article published on 22 December 2016

Rheumatoid arthritis and multiple neoplasms

scientific article published on September 28, 1991

SEOM clinical guidelines for anaplastic gliomas (2017).

scientific article

SEOM guideline for the treatment of malignant glioma

scientific article published in July 2012

SURG-01IS UNRESECTED GLIOBLASTOMA TRULY UNRESECTABLE? AN ANALYSIS OF BASAL MRI'S OF PATIENTS WITH UNRESECTED GLIOBLASTOMA INCLUDED IN THE GENOM009 TRIAL AND THE VARIABILITY OF SURGICAL APPROACHES.

scientific article

Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): a potential positive selection bias--a study of the Spanish group for research on sarcomas (GEIS).

scientific article published in October 2004

Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).

scientific article published in April 2004

Serum DNA as a tool for cancer patient management

scientific article published on 01 January 2003

Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain.

scientific article published on 21 June 2013

Stem Cells in Brain Tumorigenesis and their Impact on Therapy ⬇️

scientific article published on December 1, 2011

Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a phase II study.

scientific article

Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib

scientific article published on 20 June 2019

Translational research in glioblastoma multiforme: molecular criteria for patient selection.

scientific article published on April 2008

Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients

scientific article published in September 2011

Update on the diagnosis of cancer of unknown primary (CUP) origin

scientific article published on 01 July 2011

Use of 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas

scientific article published in August 2002

Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study.

scientific article

[2018 Consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary]

scientific article published on 10 October 2018

[Induction chemotherapy in the treatment of head and neck cancer in advanced stages]

scientific article published on 01 January 1992

Paulina is supported by:

About Paulina

Help